CompanyHealthAi
Mirador Therapeutics
Mirador Therapeutics is a San Diego precision-medicine company building first- and best-in-class therapies for immune-mediated inflammatory and fibrotic diseases. Its Mirador360 engine fuses human genetics, multi-modal patient data, AI and advanced analytics to find novel targets, design combination therapies and identify the patients most likely to respond. Founded in 2024 by the former Prometheus Biosciences leadership team, Mirador launched with more than $400 million and has since raised over $650 million total.
2024Founded
San DiegoHQ
$250MSeries B
biotechprecision-medicineimmunologyinflammationfibrosisdrug-discovery